ADA and metachromatic leukodystrophy: Patients from different diseases, such as SCID-X1, ADA-SCID, WAS, B-Thal, ALD, or MLD, have gained significant clinical benefits from this new approach,35–37 without any evidence of insertional oncogenesis using later-generation vectors.38